(19)

(11)

EP 4 355 278 A1

(12)

(43) Date of publication: 24.04.2024 Bulletin 2024/17 (21) Application number: 22825638.4 (22) Date of filing: 14.06.2022

(51) International Patent Classification (IPC):  A61F 13/02(2006.01) A61M 39/02(2006.01) A61M 39/14(2006.01) (52) Cooperative Patent Classification (CPC): A61F 13/02; A61M 39/02; A61M 2025/0266; A61F 2013/00361; A61F 2013/00412 (86) International application number: PCT/US2022/033369 (87) International publication number: WO 2022/266053 (22.12.2022 Gazette 2022/51)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 16.06.2021 US 202163211359 P 10.06.2022 US 202217838027 (71) Applicant: Neodyne Biosciences, Inc. Fremont, CA 94538 (US)	(72) Inventors: LIPMAN, Kelley J. Fremont, California 94538 (US) JACKSON, Jasper Fremont, California 94538 (US) WADLOW, Philip J. Fremont, California 94538 (US) ZEPEDA, John A. Fremont, California 94538 (US) LASRADO, Reuben E. Fremont, CA 94538 (US) (74) Representative: J A Kemp LLP  80 Turnmill Street London EC1M 5QU London EC1M 5QU (GB)